With tightening budgets and pharma/physician relationships coming under increasing scrutiny, the resulting pressure has impacted the success of the traditional medical conferencing model.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
